A recent article in Blood, a publication of the American Society of Hematology, examines thirteen years of surveillance data collected by the Centers for Disease Control and Prevention regarding patient outcomes for men with severe hemophilia. Among the key points:
Prospectively collected data on demographics, complications, and mortality are described for 4899 US men with severe hemophilia.
Analyzing multiple birth cohorts of US men with severe and mild hemophilia demonstrates ongoing morbidity in need of surveillance.
To read the article, Men with severe hemophilia in the United States: birth cohort analysis of a large national database, click here.